Serologic markers for hepatitis B virus and hepatitis a virus in Bushmen in West Caprivi, Namibia
Steele, A.D.; Bos, P.; Joubert, J.J.; Bafort, J.M.; Lecatsas, G.; Aspinall, S.
East African Medical Journal 72(1): 30-32
1995
ISSN/ISBN: 0012-835X PMID: 7781552 Document Number: 442296
A community based sero-epidemiological study was undertaken to determine the age specific prevalence rates of hepatitis A virus (HAV) and hepatitis B virus (HBV) infection in a band of Bushmen in the West Caprivi, Namibia. All children tested and all but two of the adults tested showed the presence of anti-HAV antibodies. Nineteen individuals (18%) were positive for HBsAg and 65 (61%) individuals had serologic evidence of past exposure to HBV infection.
Document emailed within 1 workday
Related Documents
Guardia, J.; Esteban, R. 1985: Serologic markers of hepatitis B virus Medicina Clinica 84(15): 612-613Sardà Jansà, N.; Santacatalina Ubiedo, L. 1994: Hepatitis b virus serologic markers Atencion Primaria 13(3): 144-145
Vargas, V.; Pedreira, J.D.; Esteban, R.; Hernández, J.M.; Piqueras, J.; Guardia, J. 1982: Serologic markers for hepatitis B virus in a group of healthy individuals Medicina Clinica 78(7): 265-267
Fedorova, O.E. 1999: Serologic markers to hepatitis E virus in residents in nonendemic regions Voprosy Virusologii 44(4): 155-158
López Martínez, R.M.; Cervera Estrany, M.; Planells Torres, P.; Juvé Saumell, R. 1994: Prevalence of serologic markers of hepatitis B virus in non-hospital health personnel Medicina Clinica 103(10): 396
Caspari, G.; Gerlich, W.H. 2007: The Serologic Markers of Hepatitis B Virus Infection - Proper Selection and Standardized Interpretation Clinical Laboratory 53(5-6): 335-343
Eisenburg, J. 1995: Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology Fortschritte der Medizin 113(3): 35-36
Eisenburg, J. 1995: Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 5: Hepatitis C serology Fortschritte der Medizin 113(4): 41-42
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Kania, D.; Sangaré, L.; Sakandé, J.; Koanda, A.; Nébié, Y.K.; Zerbo, O.; Combasséré, A.W.; Guissou, I.P.; Rouet, F.ço. 2009: A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso Transfusion 49(10): 2237-2240
Kaji, K.; Unoura, M.; Kobayashi, K.; Nakanuma, Y. 1994: Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1865-1868
Devi, K.S.; Singh, N.B.; Singh, H.L.; Singh, Y.M. 2009: Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users Journal of the Indian Medical Association 107(3): 144; 146-147
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158